Importantly, the amount of intratumor mature DCs expressing lysosome-associated membrane glycoprotein 3 (LAMP3), is closely associated with tumor-infiltrated CD8+ T cell numbers, which predict favorable prognosis in patients with ESCC (60). This evidence concerns the gene CD8A and neoplasm.